Response of MDA-MB231 cells to cisplatin and paclitaxel - viability, migration and gene expression estimation in mono- and co-culture with macrophages.

Rep Pract Oncol Radiother · 2025 · PMC12413220 · PMID 40919245

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

CisPt appears to reduce the number of viable MDA-MB231 cells, as we observed a decreasing trend in cell viability when exposed to the chemotherapeutic agent.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.